Profile
Settings
Refer your friends
Sign out
Hyderabad has made a name for itself as India’s centre for healthcare and the life sciences during the last couple of decades. It has also grown to become a significant global centre of technology. The city further enhanced its reputation during the COVID-19 epidemic by playing a crucial part in the distribution of vaccinations that helped immunise the whole world.
Key Takeaways
- The 20th BioAsia event will be held in February 2023 from 24 to 26
- This event will be conducted in Hyderabad that will host industrialists & researchers from the biotechnology and pharmaceutical industry
- The BioAsia 2023 event will be hosted by Government of Telangana and the Federation of Asian Biotech Associations (FABA)
The Need for BioAsia Events
The BioAsia event is an annual event held in Hyderabad, India. It is one of Asia’s largest gatherings of the biotechnology and pharmaceutical industry. The event focuses on networking and business opportunities and features plenary sessions, workshops, and exhibitions. This year’s event will take place from February 24-26, 2023.
The event is organized by the Government of Telangana and the Federation of Asian Biotech Associations (FABA). The event aims to promote the development of the biotechnology and pharmaceutical industry in Asia and to create a platform for networking and business opportunities.
The pandemic has highlighted the urgent need for industry, academia, authorities, legislators, and other ecosystem players to increase their engagement to ensure medical innovations are at the size and accessible for everyone.
Important Events at BioAsia
BioAsia has become one of Asia’s most important gatherings of the biotechnology and pharmaceutical industry. The event provides a unique opportunity for companies to showcase their products and services and for investors to identify potential investment opportunities.
The event also features plenary sessions, workshops, and exhibitions.
- The plenary sessions bring together leading experts from the industry to discuss the latest trends and developments
- The workshops provide a platform for companies to share their experiences and best practices
- The exhibitions provide an opportunity for companies to showcase their products and services
- It provides a platform for networking, business opportunities, and companies to showcase their products and services
Theme of BioAsia 2023
The logo and the theme of BioAsia 2023 was unveiled by Industries and IT Minister KT Rama Rao, Industries Principal Secretary Jayesh Ranjan, Life Sciences Director Shakthi Nagappan, and CEO Shakthi Nagappan. “Advancing for One: Shaping the next generation of humanized healthcare” is the conference’s slogan.
All the stakeholders will have a forum to debate and consider the prospects and challenges in humanized healthcare at BioAsia 2023.
Key Takeaways from Last Gatherings
In past years, BioAsia has been a valuable source of information and insight for attendees. Here are some of the critical things we’ve learned from previous gatherings:
1. The Importance of Collaboration
The biotechnology and pharmaceutical industries are highly competitive, and companies are often reluctant to share information with their rivals. However, attendees at BioAsia have repeatedly stressed the importance of collaboration to advance the industry as a whole.
2. The Need for Regulation
The biotechnology and pharmaceutical industries are regulated by a complex web of national and international laws. Attendees at BioAsia have emphasised the need for clear and effective regulation to protect the public and ensure the ethical development of new treatments and technologies.
3. The Power of Networking
Asia allows attendees to network with each other and lead industry figures. These connections can be valuable sources of information and advice and help open up new business opportunities.
4. The Challenges of Counterfeiting
The biotechnology and pharmaceutical industries are particularly vulnerable to counterfeiting, a significant topic of discussion at BioAsia. Attendees highlighted the need for better regulation and enforcement of intellectual property rights and greater public awareness of the problem.
5. The Importance of Research and Development
The biotechnology and pharmaceutical industries are constantly evolving, and companies must invest heavily in research and development to stay ahead of the competition. Attendees at BioAsia emphasized the need for companies to focus on innovation and invest in the next generation of products and technologies.
6. The Role of Government
The government plays a vital role in the biotechnology and pharmaceutical industries, both as a regulator and as a source of funding for research and development. Attendees at BioAsia have called for greater government support for the industry in terms of regulation and funding.
7. The Need for Ethical Standards
The biotechnology and pharmaceutical industries are subject to strict ethical standards, and attendees at BioAsia have emphasised the need for companies to adhere to these standards. In particular, there is a need for greater transparency in developing and testing new treatments and technologies.
8. The Future of the Industry
The biotechnology and pharmaceutical industries are facing several challenges, including the need for greater regulation, the threat of counterfeiting, and the need for continued investment in research and development. However, attendees at BioAsia remain optimistic about the industry’s future and believe it will continue to grow and thrive in the years to come.
9. The Role of the Private Sector
The private sector plays a vital role in the source of funding for research and development and as a provider of products and services. Attendees at BioAsia have called for greater cooperation between the public and private sectors to advance the industry.
10. The Need for Global Cooperation
The biotechnology and pharmaceutical industries are global, and companies often operate in multiple countries. Attendees at BioAsia have emphasized the need for greater collaboration between countries to advance the industry and protect the public.
Virtually the 13th BioAsia conference took place from February 22–26, 2021. With the involvement of 37,500 delegates from 70 countries, the event was a major success. Industry titans including Paul Polman (Former CEO of Unilever), Alex Gorsky (Executive Chairman of Johnson & Johnson), Dr. Vas Narasimhan (CEO of Novartis), Geoff Martha (Chairman and CEO of Medtronic), and Bill Gates (Co-founder of Microsoft) participated at the event.
